These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 21796651

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Epigenetic modifications of prostate-derived Ets transcription factor in breast cancer cells.
    Sabherwal Y, Mahajan N, Zhang M.
    Oncol Rep; 2013 Oct; 30(4):1985-8. PubMed ID: 23921628
    [Abstract] [Full Text] [Related]

  • 7. Prostate-derived Ets factor, an oncogenic driver in breast cancer.
    Sood AK, Geradts J, Young J.
    Tumour Biol; 2017 May; 39(5):1010428317691688. PubMed ID: 28468594
    [Abstract] [Full Text] [Related]

  • 8. Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated molecules.
    Ghadersohi A, Odunsi K, Lele S, Collins Y, Greco WR, Winston J, Liang P, Sood AK.
    Oncol Rep; 2004 Feb; 11(2):453-8. PubMed ID: 14719083
    [Abstract] [Full Text] [Related]

  • 9. NKX-3.1 interacts with prostate-derived Ets factor and regulates the activity of the PSA promoter.
    Chen H, Nandi AK, Li X, Bieberich CJ.
    Cancer Res; 2002 Jan 15; 62(2):338-40. PubMed ID: 11809674
    [Abstract] [Full Text] [Related]

  • 10. HOXB13 regulates the prostate-derived Ets factor: implications for prostate cancer cell invasion.
    Kim IJ, Kang TW, Jeong T, Kim YR, Jung C.
    Int J Oncol; 2014 Aug 15; 45(2):869-76. PubMed ID: 24898171
    [Abstract] [Full Text] [Related]

  • 11. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen.
    Ghadersohi A, Sood AK.
    Clin Cancer Res; 2001 Sep 15; 7(9):2731-8. PubMed ID: 11555586
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors.
    Rodabaugh KJ, Mhawech-Fauceglia P, Groth J, Lele S, Sood AK.
    Int J Gynecol Pathol; 2007 Jan 15; 26(1):10-5. PubMed ID: 17197890
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tumor metastasis suppressor functions of Ets transcription factor through integrin β3-mediated signaling pathway.
    Pal M.
    J Cell Physiol; 2019 Nov 15; 234(11):20266-20274. PubMed ID: 30982973
    [Abstract] [Full Text] [Related]

  • 18. ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer.
    Turner DP, Watson DK.
    Expert Rev Anticancer Ther; 2008 Jan 15; 8(1):33-42. PubMed ID: 18095881
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.
    Turner DP, Findlay VJ, Moussa O, Semenchenko VI, Watson PM, LaRue AC, Desouki MM, Fraig M, Watson DK.
    Prostate; 2011 Dec 15; 71(16):1723-35. PubMed ID: 21446014
    [Abstract] [Full Text] [Related]

  • 20. Silibinin down-regulates prostate epithelium-derived Ets transcription factor in LNCaP prostate cancer cells.
    Thelen P, Jarry H, Ringert RH, Wuttke W.
    Planta Med; 2004 May 15; 70(5):397-400. PubMed ID: 15124082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.